MilliporeSigma Awards Grants to Biotechs Focused on Traumatic Brain Injury, Vaccine Development and Chronic Pain
Three U.S. companies awarded MilliporeSigma’s Advance Biotech Grant to advance molecule-to-market efforts Burlington, Massachusetts, May 30, 2019 — MilliporeSigma today announced the winners of its Advance Biotech Grant program in North America during its Biotech Start-up Summit at the Cambridge Innovation Center. The grant is given to small- and mid-size biotechnology companies that need funding and expertise to... Read more